Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Human T-cell leukemia virus x gene.

W Wachsman, D Slamon, K Shimotohno

Cancer Research

|September 1, 1985

Summary

Researchers identified a conserved gene, termed x, within the X sequences of human T-cell leukemia viruses (HTLV) types I and II. This gene

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329].

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Same author

Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Prognostic gene expression signature for high-grade serous ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Area of Science:

Virology
Oncology
Molecular Biology

Background:

Human T-cell leukemia virus (HTLV) types I and II are linked to hematological cancers.
These viruses possess the ability to rapidly transform normal T-lymphocytes in vitro.
The precise mechanism driving HTLV-induced leukemogenesis remains undetermined.

Purpose of the Study:

To investigate the function of conserved sequences, termed X, in HTLV-I and HTLV-II.
To determine if these conserved X sequences encode functional genes.
To explore the potential role of the X gene in viral replication and leukemogenesis.

Main Methods:

Structural analysis of HTLV-I and HTLV-II proviral genomes.
Identification of subgenomic X RNA.
Detection of proteins encoded by X messages.

Main Results:

Conserved X sequences within HTLV-I and HTLV-II genomes contain a gene, designated x.
This x gene is expressed in both HTLV-I and HTLV-II.
A subgenomic X RNA and its encoded proteins were identified.

Conclusions:

The conserved X sequences in HTLV-I and HTLV-II harbor an expressed gene (x).
The function of the x gene is currently unknown.
Its conservation and expression suggest a potential role in HTLV replication and leukemogenesis.

Related Experiment Videos